Omnicell (OMCL) appoints Perry Genova as CTO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
March 24, 2025 4:01 PM EDTMedical device, pharmaceutical, and life sciences expert tapped to lead Companys technology strategy and global engineering organization
FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq: OMCL) (Omnicell or the Company), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.
This press release features multimedia. View the full release here:... More
